John Beadle

Prevention of liver cancer cachexia-induced cardiac wasting and heart failure

Jochen Springer, Anika Tschirner, Arash Haghikia et al. · European Heart Journal · 2013 · 207 citations · Full text

Medicine, Oncology, Pharmacology +13

Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)

Andrew J.S. Coats, Gwo Fuang Ho, Kumar Prabhash et al. · Journal of Cachexia Sarcopenia and Muscle · 2016 · 172 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Rocio García‐Carbonero, Ramón Salazar, Ignacio Durán et al. · Journal for ImmunoTherapy of Cancer · 2017 · 159 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +13

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

Suzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn et al. · Vaccine · 2009 · 140 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey et al. · Journal for ImmunoTherapy of Cancer · 2019 · 104 citations · Full text

Medicine, Oncology, Pharmacology +15